Evolution of COVID‐19 infection in four psoriatic patients treated with biological drugs
Author:
Affiliation:
1. Department of Surgical Medical, Dental and Morphological Sciences related to Transplant, Oncology and Regenerative Medicine Dermatology Unit University of Modena and Reggio Emilia Modena Italy
Publisher
Wiley
Subject
Infectious Diseases,Dermatology
Link
https://onlinelibrary.wiley.com/doi/pdf/10.1111/jdv.16587
Reference8 articles.
1. Should biologics for psoriasis be interrupted in the era of COVID-19?
2. SARS‐CoV‐2 infection in a psoriatic patient treated with IL‐23 inhibitor
3. Clinical features of patients infected with 2019 novel coronavirus in Wuhan, China
4. Inhibition of the inflammatory cytokine tumor necrosis factor-alpha with etanercept provides protection against lethal H1N1 influenza infection in mice
5. Research progress on the mechanism of cytokine storm induced by new coronavirus pneumonia and related immunotherapy [J/OL];Chen C;Chin J Burns,2020
Cited by 40 articles. 订阅此论文施引文献 订阅此论文施引文献,注册后可以免费订阅5篇论文的施引文献,订阅后可以查看论文全部施引文献
1. Psoriasis and biological drugs at the time of SARS-CoV-2 infection: a mini review outlining risk of infection, seroprevalence, and safety and efficacy of the BNT162b2 vaccine;Frontiers in Immunology;2024-01-30
2. A systematic review and meta‐analysis of investigating the mutual impact of COVID‐19 and psoriasis: Focusing on COVID‐19 course in psoriasis and the opinion on biologics in this setting;Immunity, Inflammation and Disease;2023-11
3. Interleukin Receptor Antagonists and Janus Kinase Inhibitors Repurposed for Treatment of COVID-19;Mini-Reviews in Medicinal Chemistry;2022-11
4. Treatment of Moderate to Severe Psoriasis during the COVID-19 Pandemic: Lessons Learned and Opportunities;Journal of Clinical Medicine;2022-04-26
5. The Cytokine Storm in COVID-19: The Strongest Link to Morbidity and Mortality in the Current Epidemic;COVID;2022-04-25
1.学者识别学者识别
2.学术分析学术分析
3.人才评估人才评估
"同舟云学术"是以全球学者为主线,采集、加工和组织学术论文而形成的新型学术文献查询和分析系统,可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容,当前同舟云学术共收录了国内外主流学术期刊6万余种,收集的期刊论文及会议论文总量共计约1.5亿篇,并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询!咨询电话:010-8811{复制后删除}0370
www.globalauthorid.com
TOP
Copyright © 2019-2024 北京同舟云网络信息技术有限公司 京公网安备11010802033243号 京ICP备18003416号-3